cisplatin,carboplatin,atezolizumab
roche
['muc ,(-much)', 'atezo', 'cisplatin', 'urothelial', 'urothelial carcinoma', ' cis ', 'imvigor130', 'core 1', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nct02807636', 'carboplatin', 'imvigor,11']
final overall survival (os) analysis of atezolizumab (atezo) monotherapy vs chemotherapy (chemo) in untreated locally advanced or metastatic urothelial carcinoma (muc) from the phase 3 imvigor130 study #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid